Trinucleotide mRNA Cap Analogue


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
05 Mar 2024
Historique:
medline: 5 3 2024
pubmed: 5 3 2024
entrez: 5 3 2024
Statut: aheadofprint

Résumé

Eukaryotic mRNAs undergo cotranscriptional 5'-end modification with a 7-methylguanosine cap. In higher eukaryotes, the cap carries additional methylations, such as

Identifiants

pubmed: 38442005
doi: 10.1021/jacs.3c12629
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Marcin Warminski (M)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-089 Warsaw, Poland.

Edyta Trepkowska (E)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Miroslaw Smietanski (M)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Pawel J Sikorski (PJ)

Centre of New Technologies, University of Warsaw, 02-089 Warsaw, Poland.
Laboratory of Epitranscriptomics, Department of Environmental Microbiology and Biotechnology, Institute of Microbiology, Faculty of Biology, Biological and Chemical Research Centre, University of Warsaw, 02-089 Warsaw, Poland.

Marek R Baranowski (MR)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Marcelina Bednarczyk (M)

Centre of New Technologies, University of Warsaw, 02-089 Warsaw, Poland.
Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Hanna Kedzierska (H)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Bartosz Majewski (B)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Adam Mamot (A)

Centre of New Technologies, University of Warsaw, 02-089 Warsaw, Poland.

Diana Papiernik (D)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Agnieszka Popielec (A)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Remigiusz A Serwa (RA)

Proteomics Core Facility, IMol Polish Academy of Sciences, 02-247 Warsaw, Poland.

Brittany A Shimanski (BA)

Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States.

Piotr Sklepkiewicz (P)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Marta Sklucka (M)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Olga Sokolowska (O)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Tomasz Spiewla (T)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-089 Warsaw, Poland.
Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Diana Toczydlowska-Socha (D)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Zofia Warminska (Z)

Centre of New Technologies, University of Warsaw, 02-089 Warsaw, Poland.

Karol Wolosewicz (K)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Joanna Zuberek (J)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-089 Warsaw, Poland.

Jeffrey S Mugridge (JS)

Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States.

Dominika Nowis (D)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.
Laboratory of Experimental Medicine, Faculty of Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland.

Jakub Golab (J)

Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.
Laboratory of Experimental Medicine, Faculty of Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland.

Jacek Jemielity (J)

Centre of New Technologies, University of Warsaw, 02-089 Warsaw, Poland.
Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Joanna Kowalska (J)

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-089 Warsaw, Poland.
Explorna Therapeutics sp. z o.o. Zwirki i Wigury 93, 02-089 Warsaw, Poland.

Classifications MeSH